News

Zoomd Set to Share 2024 Financial Performance Insights

Zoomd Set to Share 2024 Financial Performance Insights

Zoomd Plans to Reveal 2024 Financial Results

Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF), a significant player in the marketing technology space, has announced its schedule for revealing the financial results for the fourth quarter and full year of 2024. This is an essential moment for stakeholders and interested parties looking to understand the company’s performance and future outlook.

Conference Call Scheduled for Stakeholder Engagement

On March 26, 2025, Zoomd will conduct a conference call at 11 a.m. ET, aimed at discussing its results and offering corporate updates. These calls are instrumental for investors to gain insights directly from the company leaders, clarifying their growth strategies and operational insights.

Accessing the Conference Call

Individuals interested in participating can find the conference call through an Internet webcast, made accessible in the Investors section of the Company's website. This open invitation is part of Zoomd's commitment to transparency and engagement with its investor base.

About Zoomd's Innovative Platform

Founded in 2012 and publicly traded since September 2019, Zoomd is globally recognized for its mobile app user-acquisition solutions, which help streamline the complexities of digital marketing. This innovative platform integrates numerous digital media sources, empowering advertisers to manage their campaigns from a single point of contact. By unifying multiple media outlets, Zoomd assists in optimizing customer acquisition strategies, which can lead to cost savings and improved operational efficiency.

Enhancing Advertiser Efficiency

Zoomd's approach mitigates the challenges advertisers face when juggling different data sources. The platform enhances data collection and analytical capabilities, allowing for a more effective marketing strategy. This capability is crucial as businesses seek to optimize their advertising spending and maximize engagement with potential users.

Commitment to Transparency in Communications

Zoomd is dedicated to providing its stakeholders with clear and accurate information. However, it's important to note that the company also includes a disclaimer about forward-looking statements in its communications. These statements outline the potential growth paths and strategies that might unfold, but they also acknowledge the inherent uncertainties and risks involved. Stakeholders are encouraged to consider these factors carefully when assessing the company's prospects.

Disclaimer on Forward-Looking Statements

Forward-looking statements reflect plans and expectations based on current assumptions, but actual outcomes may vary significantly due to various factors. These include economic fluctuations, competitive conditions, and the company’s response to technological changes and global events.

Contact Information for Stakeholder Inquiries

For further queries, stakeholders can reach out to Amit Bohensky, the Chairman of Zoomd, or the investor relations team at Lytham Partners, LLC. They are available to assist with any inquiries regarding the company's performance and strategic direction.

Frequently Asked Questions

What is the date for Zoomd's next conference call?

The conference call is scheduled for March 26, 2025, at 11 a.m. ET.

How can I access the conference call?

Access details for the conference call will be available on the Company’s website in the Investors section.

What does Zoomd specialize in?

Zoomd specializes in marketing technology, specifically providing an innovative platform for mobile app user acquisition and engagement.

When was Zoomd listed on the stock exchange?

Zoomd has been listed on the TSX Venture Exchange since September 2019.

Who can I contact for more information about Zoomd?

You can contact Amit Bohensky, the Chairman, or reach out to the investor relations team at Lytham Partners for any inquiries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Radiofrequency Microneedling: A Fresh Skin Solution?

Updated Category News Views 128

Vet the Process Before Diving In Everyone wants to turn back the clock on their skin, but it's crucial to know what you're getting into. This ain't a quick splash of water on the face; it's radiofrequency microneedling we're talking about. And honey, it’s no fairy tale—it’s science, plain and simple. Drilling Down on Microneedling This procedure, preached by Dr....

Continue Reading
Purina's Docuseries Wins Big at Daytime Emmys

Updated Category News Views 89

Unleashing a Winning Streak Forget stock price fluctuations—Purina Films has struck gold. In a world where brand stories often fall flat or feel contrived, Purina's 'A Different Breed' docuseries just bagged three Daytime Emmy® Awards. It's not every day you see corporate storytelling make a splash like this, but when you blend pets and riveting narratives, magic...

Continue Reading
Flash Tech Sparks New Era in Gas Sensing

Updated Category News Views 38

Revolutionary 10-Millisecond Flash Technique Out of South Korea comes a scientific shake-up that's got eyes on a tiny flash of light poised to change gas sensing technology as we know it. Yep, at Hanyang University ERICA, the boffins have figured out how a quick-fire 10-millisecond zap can turn up the sensitivity dial on gas sensors, especially for the pesky nitrogen...

Continue Reading
KickHouse Partners with Sam Alvey for Glove Line Launch

Updated Category News Views 40

KickHouse Pounces with New Fighter Partnership Looks like KickHouse isn't playing games, folks. They've teamed up with fighter Sam Alvey to launch a new boxing glove line. You got your Warbird, your Desert Ghost, and your Night Ops gloves—names straight out of a war zone. These 16-ounce hammers are out now, and they kickstart a broader gear lineup custom-built for Alvey...

Continue Reading
BioArctic's Moves: Lecanemab Data and Leadership Insights

Updated Category News Views 79

BioArctic's Power Play: A Two-Pronged Update Ever feel like biotechnology is just a series of chess moves? BioArctic's recent maneuvers in the life sciences game certainly hint at that. First, they've got data brewing on lecanemab—this ain't small beans, folks, not with Alzheimer's disease in the crosshairs. Then there's their Nomination Committee. It’s like shaking...

Continue Reading
Ping Identity Tops 2026 Gartner Magic Quadrant: CIAM

Updated Category News Views 20

Turning Heads in the Cybersecurity Space When it comes to digital security, Ping Identity has snagged a top spot in Gartner's 2026 Magic Quadrant for Customer Identity and Access Management (CIAM). Some might gloss over these annual reports like yesterday's news, but Ping isn't just playing around here. They've been tapped as a Leader again, and this accolade highlights...

Continue Reading
Glance's Guide Bridges AI and Human Service Gaps

Updated Category News Views 117

Untangling the AI to Human Transition Ever found yourself stuck in a never-ending loop with AI, screaming for a human voice? You're not alone. According to Glance's 2026 Customer Experience Trends Report, a staggering 76% of consumers are pulling their hair out while repeating themselves when switching service channels. The rub? Only 7% claim they rarely experience this...

Continue Reading
Holiday Shoppers Eye Payment Options Amid Tight Budgets

Updated Category News Views 67

Shoppers Feel the Squeeze As Holidays Approach Hope you brought your umbrella because the holiday season is going to be awash with financial strain and stress for many consumers. According to the latest ETA-TSG Consumer Holiday Spending Study, 44% of consumers are more financially stressed this year compared to last, and the numbers aren't getting any rosier from there....

Continue Reading
Winter Travel Booms: Top Destinations Unveiled for 2026

Updated Category News Views 121

Winter Travel Surge: Rising Demand for Top Destinations Every year as the temperature drops, the excitement for winter travel heats up, and this season's no different. Booking patterns confirm that while people are dreaming of holiday magic, they're also gunning for sun when cold's on the horizon. New York City's holiday glitz leads the domestic charge, backed by a power...

Continue Reading
Orbis International to Boost Global Eye Health Efforts

Updated Category News Views 100

Pledge for Vision In a world where a staggering number of folks wrestle with avoidable vision issues, Orbis International is stepping up to the plate with ambitions that feel as bold as they are necessary. Orbis is pouring a significant $32 million into its mission to beef up eye health systems, train a small army of professionals, and apply AI in eye care. Their big bet...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Developments in Titanium Powder Production by PyroGenesis

Updated Category News Views 156

Significant Contract for Titanium Powder Production PyroGenesis Inc., a pioneer in ultra-high temperature processes and a leading technology provider to heavy industry and defense, is making waves in the additive manufacturing sector. The company has announced an initial order for 'fine cut' titanium powder, which has been produced using their advanced NexGen™ plasma...

Continue Reading
Exploring The Impressive Returns of The Hartford Insurance

Updated Category News Views 254

Understanding The Hartford Insurance Group's Growth The Hartford Insurance Group (NYSE: HIG) has displayed impressive market performance over the past five years, outpacing overall market gains significantly. With an annualized return of 26.43%, this company has offered a noteworthy 12.44% lead over the market average. Current market capitalization stands at approximately...

Continue Reading
Exciting New Consumer Product Launches and Trends This Week

Updated Category News Views 520

Highlights of this Week’s Major Consumer Announcements This week brings an exciting selection of consumer and retail news that you won’t want to miss. From the world of fragrances to the latest Halloween trends, here’s a closer look at some captivating announcements that are making waves. Ariana Grande’s Wicked-Inspired Fragrances Ariana Grande has taken things to...

Continue Reading
Occidental Petroleum's Significant Debt Reduction Achievements

Updated Category News Views 274

Occidental Petroleum's Debt Reduction Strategy In a significant stride towards enhancing its financial health, Occidental Petroleum (NYSE: OXY) announced remarkable progress in its debt reduction efforts, achieving a key target of $4.5 billion by the end of 2024. This noteworthy milestone positions the company well as it navigates the complexities of the evolving energy...

Continue Reading
Aptose Unveils Promising New Therapy for AML Patients

Updated Category News Views 218

Aptose Unveils Promising New Therapy for AML Patients In a groundbreaking development, Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS) recently announced that the initial patients have been dosed in the TUSCANY Phase 1/2 trial. This innovative trial evaluates the effectiveness of tuspetinib (TUS) in combination with venetoclax (VEN) and azacitidine (AZA). This trio...

Continue Reading